Cargando…
Teriflunomide-Induced Palmoplantar Pustular Psoriasis: Case Report and Review of the Literature
Teriflunomide is a once-daily oral immunomodulatory disease-modifying treatment for multiple sclerosis (MS). Skin reactions are an infrequent side effect of teriflunomide. Here, we present the case of a 52-year-old female patient with ankylosing spondylitis who was consulted for demyelinating lesion...
Autores principales: | Demirel Ozbek, Ezgi, Akdogan, Neslihan, Ates Ozdemir, Deniz, Acar Ozen, Nazire Pinar, Tuncer, Aslı |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472710/ https://www.ncbi.nlm.nih.gov/pubmed/37664364 http://dx.doi.org/10.7759/cureus.42845 |
Ejemplares similares
-
Palmoplantar Psoriasis Successfully Treated With Risankizumab
por: Alajlan, Abdulmajeed M, et al.
Publicado: (2021) -
Biologics and Pediatric Generalized Pustular Psoriasis: An Emerging Therapeutic Trend
por: Saikaly, Sami K, et al.
Publicado: (2016) -
Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
por: Kim, Tae Hyung, et al.
Publicado: (2022) -
Clinical characteristics and associations of palmoplantar pustulosis: an observational study()()
por: Oktem, Ayse, et al.
Publicado: (2020) -
Tozinameran: Exacerbations of generalised pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris: 3 case reports
Publicado: (2022)